The NHS England (Alternative Treatment) Bill requires the Secretary of State to make regulations establishing a scheme that gives patients registered with the NHS in England, who have waited more than one year for hospital treatment, access to hospital care that is not provided by NHS England. The scheme must cover both access and payment arrangements for such non‑NHS treatment, and it must set out how to calculate how long a patient has been awaiting NHS hospital treatment.
The regulations must be made by statutory instrument and are subject to the affirmative resolution procedure; they must be laid and approved by both Houses. The Act also specifies that the cost of delayed treatment under the scheme is to be met by NHS England, and it comes into force three months after Royal Assent, applying to England and Wales only.
The bill is a framework statute: it creates a legal duty to make detailed secondary legislation but leaves operational design to those forthcoming regulations.
At a Glance
What It Does
The bill obliges the Secretary of State to make secondary legislation establishing a scheme that allows patients waiting more than one year for NHS hospital treatment to obtain hospital care that may be provided outside NHS England, and to ensure payment arrangements for that care.
Who It Affects
Directly affected are NHS‑registered patients with waits exceeding 12 months, NHS England as the funding body, the Department of Health and Social Care as the regulator making rules, and non‑NHS hospital providers that could deliver commissioned care.
Why It Matters
The measure shifts unresolved elective‑care choice toward a statutory entitlement to alternative providers when waits exceed a year, creates a new funding obligation on NHS England, and delegates key operational design to regulations that Parliament must affirm.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill is short and narrowly framed: it does not itself set operational rules but requires the Secretary of State to produce regulations that establish a scheme for patients who have waited more than one year for NHS hospital treatment. Those regulations must address two linked issues — how a patient gains access to treatment that may be outside NHS England’s direct provision, and how payment for that treatment will be handled.
The Act makes NHS England responsible for meeting the costs of the delayed treatment but leaves mechanics, eligibility criteria, referral pathways and provider contracting to the future regulations.
The text expressly requires the regulations to define how to calculate the length of time a patient has been awaiting hospital treatment. That is a meaningful drafting point: it puts the duty on drafters to settle technical questions such as when a wait starts (referral, listing, or clinical decision point), whether intervening clinical changes reset the clock, and how to treat suspended waits — issues that will determine who becomes eligible for alternative provision.The bill uses delegated legislation rather than prescribing rules in the primary Act.
It therefore creates a mandatory—but flexible—framework: Parliament will consider an affirmative statutory instrument rather than detailed statutory text, and ministers keep discretion over the scheme’s design. The Act also sets a timetable for commencement (three months after Royal Assent) and for laying regulations (a statutory requirement to make them), concentrating the substantive policy choice into the secondary‑law stage.Because the Act extends to England and Wales only and ties funding to NHS England, the regulations will have to reconcile national policy choices with local commissioning arrangements in integrated care systems and with existing NHS rules on elective access and patient choice.
The bill therefore creates a short directive with potentially wide operational and budgetary effects once the regulations fill in the many procedural blanks.
The Five Things You Need to Know
The Secretary of State must, by regulations, establish a scheme giving NHS‑registered patients who have waited more than one year for hospital treatment access to hospital care not provided by NHS England.
The required scheme must include arrangements both for access to alternative treatment and for payment for treatment delivered outside NHS England.
The regulations must specify how to calculate the length of time a patient has been awaiting NHS hospital treatment, a determination that will define eligibility.
The Act makes NHS England responsible for funding the cost of delayed treatment provided under the scheme.
Regulations must be made by statutory instrument, be subject to the affirmative (both‑Houses) procedure, and the Act comes into force three months after Royal Assent.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Duty to make regulations and scope of the scheme
Subsection (1) creates a statutory duty on the Secretary of State to make regulations setting up a scheme that grants access to hospital treatment for patients who have waited more than one year. Subsection (2) clarifies that the scheme must include arrangements that allow access to, and payment for, treatment that is not provided by NHS England — in other words, the scheme can commission or pay for independent or private hospital treatment as a substitute for delayed NHS provision. Practically, this converts a policy intention into a delegated‑law obligation while leaving the specific eligibility and operational mechanics for the regulations.
Requirement to define how a waiting period is calculated
This clause forces the regulations to set a precise method for calculating a patient’s wait time. That is an operationally important mandate: the regulations must choose a commencement point (for example, date of referral, referral acceptance or placement on a waiting list), address suspensions and restarts, and decide how to treat changes in clinical prioritisation. These technical choices will determine the size of the cohort eligible for alternative treatment and shape administrative work for commissioners and providers.
Funding responsibility assigned to NHS England
The Act states that the cost of delayed treatment under the scheme is to be funded by NHS England. That places the financial burden on the national commissioning body rather than on individual trusts, patients, or the Department of Health and Social Care directly. In implementation this will require NHS England to create budgets, payment routes to non‑NHS providers, and rules to prevent double‑charging or conflicting payments with local commissioning arrangements.
Timing and parliamentary procedure for the regulations
The bill sets deadlines and parliamentary oversight: regulations must be made no later than six months after the Act comes into force, must be created by statutory instrument, and cannot be made unless the draft instrument is laid before and approved by resolution of each House. This affirmative procedure gives Parliament a direct say over the regulations’ content but confines substantive detail to secondary legislation drafted by ministers.
Extent, commencement and short title
Section 2 limits the Act’s territorial extent to England and Wales, specifies that the Act comes into force three months after Royal Assent, and provides the short title. The geographic limitation combined with funding by NHS England means implementation will be focused on NHS England’s commissioning structures; devolved administrations (Scotland and Northern Ireland) are unaffected by this Act.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Patients registered with the NHS in England who have waited more than one year — they gain a statutory route to alternative hospital treatment and payment for care outside NHS England that could shorten waits for clinically necessary procedures.
- Independent and private hospital providers — the scheme creates a potential new revenue stream because regulations expressly permit procurement or payment for non‑NHS treatment.
- Patient advocacy organisations focused on elective access — the framework gives them a clear statutory lever to press for timely alternative provision once regulations are in place.
Who Bears the Cost
- NHS England — the Act assigns NHS England responsibility for funding the cost of delayed treatment, creating a new budgetary obligation and potential pressure on other commissioning priorities.
- Departmental and commissioning staff — the Secretary of State and NHS England will need to draft, implement and administer regulations, creating administrative, contracting and case‑management burdens for central and local bodies.
- Integrated care systems and hospital trusts — they may face operational and financial knock‑on effects (patient flow changes, contract adjustments, and resource reallocation) as alternative‑treatment placements are arranged under the new scheme.
Key Issues
The Core Tension
The bill pits two legitimate aims against each other: speeding access for individuals stuck on long waiting lists by permitting commissioned non‑NHS treatment, versus protecting NHS planning, budgets and equitable allocation of limited capacity — a choice between targeted relief for long‑wait patients and potential reallocation of scarce public resources with uncertain distributional effects.
Although the Act mandates a scheme, it leaves almost every material detail to secondary legislation. That delegation creates both flexibility and uncertainty: ministers can design a scheme quickly but Parliament and stakeholders will not see operational rules until the statutory instrument.
The requirement to define how waiting time is calculated highlights a core implementation challenge — small drafting choices (when a wait begins, handling of suspended waits, clinical reclassifications) will materially change who qualifies and how many placements are needed. Those technical decisions will drive fiscal exposure for NHS England and administrative load for commissioners.
Assigning costs to NHS England resolves who pays on paper, but it does not create a new ring‑fenced budget. In practice, NHS England will have to find funds within existing allocations, potentially redirecting money from other programmes or elective recovery plans.
The bill also risks creating regional variation and equity concerns: if implementation relies on availability of independent sector capacity, patients in areas with limited independent provision may continue to wait, or funds may flow unevenly to areas with capacity, exacerbating geographic disparities. Finally, the affirmative SI route gives Parliament oversight but limits scrutiny to what ministers present; significant operational trade‑offs could therefore be baked into regulations with limited opportunity for detailed amendment in primary form.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.